Key result
Biomarkers in idiopathic pulmonary fibrosis and pulmonary arterial hypertension are approaching clinical relevance as important signals for disease management.
Answers are grounded in this paper and cite their sources.
Recent studies identify ATIII and OPN as promising biomarkers for disease severity in IPF and PAH, respectively, though larger validation cohorts are needed.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2019) studied this question. Biomarkers in idiopathic pulmonary fibrosis and pulmonary arterial hypertension are approaching clinical relevance as important signals for disease management.
Synapse has enriched 10 related papers. Consider them for comparative context: